Data / Drug companies / AstraZeneca Pharmaceuticals LP
AstraZeneca Pharmaceuticals LP: 17 products in the FDA NDC directory, labeler code 0186
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
AstraZeneca Pharmaceuticals LP (labeler code 0186) lists 17 products in the FDA National Drug Code Directory, covering 4 finished drugs by generic name. By type: 14 prescription drugs, 3 drugs for further processing. Its main marketing category is new drug applications (NDA). The newest product started marketing on September 4, 2015.
The request: Watch AstraZeneca Pharmaceuticals LP (FDA labeler code 0186): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 0186
- Products in commercial distribution
- 17
- Packages
- 22
- Finished drugs by generic name
- 4
- Prescription products
- 14
- Over the counter products
- 0
- Flagged as original packager
- 14 of 14 products that carry the flag
- Started marketing in the last 12 months
- 0
- Earliest marketing start
- September 8, 2000
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| New drug applications (NDA) | 14 | 82.4% |
| Drugs for further processing | 3 | 17.6% |
Products by type
| Type | Products | Share |
|---|---|---|
| Prescription drugs | 14 | 82.4% |
| Drugs for further processing | 3 | 17.6% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
| Drug | Products | Companies listing it |
|---|---|---|
| Esomeprazole magnesium | 7 | 77 |
| Budesonide | 3 | 40 |
| Budesonide and formoterol fumarate dihydrate | 2 | 5 |
| Ticagrelor | 2 | 32 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Granule, delayed release | 5 | 29.4% |
| Capsule, delayed release | 5 | 29.4% |
| Suspension | 3 | 17.6% |
| Aerosol | 2 | 11.8% |
| Tablet | 2 | 11.8% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
| Class | Products |
|---|---|
| Proton Pump Inhibitor | 7 |
| Corticosteroid | 5 |
| beta2-Adrenergic Agonist | 2 |
| P2Y12 Platelet Inhibitor | 2 |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Brilinta | 0186-0776 | Tablet | New drug applications (NDA) | September 4, 2015 |
| Omeprazole magnesium | 0186-0743 | Capsule, delayed release | Drugs for further processing | January 1, 2015 |
| Omeprazole magnesium | 0186-0742 | Capsule, delayed release | Drugs for further processing | January 1, 2015 |
| Omeprazole magnesium | 0186-0606 | Capsule, delayed release | Drugs for further processing | January 1, 2015 |
| Nexium | 0186-4050 | Granule, delayed release | New drug applications (NDA) | June 1, 2012 |
| Nexium | 0186-4025 | Granule, delayed release | New drug applications (NDA) | June 1, 2012 |
| Brilinta | 0186-0777 | Tablet | New drug applications (NDA) | August 5, 2011 |
| Nexium | 0186-4010 | Granule, delayed release | New drug applications (NDA) | July 7, 2008 |
| Pulmicort respules | 0186-1990 | Suspension | New drug applications (NDA) | September 17, 2007 |
| Symbicort | 0186-0372 | Aerosol | New drug applications (NDA) | May 29, 2007 |
| Symbicort | 0186-0370 | Aerosol | New drug applications (NDA) | May 29, 2007 |
| Nexium | 0186-4040 | Granule, delayed release | New drug applications (NDA) | March 19, 2007 |
| Nexium | 0186-4020 | Granule, delayed release | New drug applications (NDA) | March 19, 2007 |
| Nexium | 0186-5040 | Capsule, delayed release | New drug applications (NDA) | March 19, 2001 |
| Nexium | 0186-5020 | Capsule, delayed release | New drug applications (NDA) | March 19, 2001 |
| Pulmicort respules | 0186-1989 | Suspension | New drug applications (NDA) | September 8, 2000 |
| Pulmicort respules | 0186-1988 | Suspension | New drug applications (NDA) | September 8, 2000 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.